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Background: In particular surgical conditions, a balanced anesthesia with a high-antinociceptive contribution is
required. This may induce cardiovascular impairment and thus compromise tissue oxygenation. In this prospective
observational study, we investigated the hemodynamic stability and tissue oxygen saturation (StO2) in 40 patients
with a high-antinociceptive general anesthesia, goal-directed fluid therapy, and norepinephrine. In addition, optimal
surgical conditions and safe and fast emergence are pivotal parts of anesthetic management.
Methods: In high-antinociceptive propofol/remifentanil anesthesia with bispectral index (BIS) between 40 and 60,
norepinephrine was administered to maintain mean arterial pressure (MAP) above 80% of individual baseline. Fluid
was administered if the Δ plethysmographic waveform amplitude exceeded 10%. Surgical and recovery conditions,
hemodynamic responses, and tissue oxygenation were investigated.
Results: Mean (SD) StO2 at the left thenar eminence increased from 83 (6)% before to 86 (4)% 20 min after induction
of anesthesia (p <0.05). Cardiac index dropped from 3.0 (0.7) to 2.1 (0.4) L min−1 (p <0.05), MAP from 109 (16) to 83
(14) mm Hg, and heart rate from 73 (12) to 54 (8) bpm (p <0.05). Thirteen out of 40 patients received a fluid bolus.
The median (range) norepinephrine administration rate was 0.05 (0.0–0.10) μg kg−1 min−1. After complete akinesia
in all patients during surgery, a median (IQR) extubation time of 311 (253–386) s was observed.
Conclusions: This high-antinociceptive balanced anesthesia with goal-directed fluid and vasopressor therapy
adequately preserved StO2 and hemodynamic homeostasis.
Trial registration: ISRCTN20153044
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NorepinephrineBackground
Induction to a level of anesthesia adequate to tolerate
laryngoscopy requires a combination of hypnotics and
analgesics that may induce significant hemodynamic
suppression attributed to peripheral vasodilatation, loss
of venous tone causing reduction in preload and venous
return, and to a lesser extent, a decreased myocardial
contractility. After intubation, the sudden decrease
in nociceptive stimuli often results in hypotension* Correspondence: j.j.vos@umcg.nl
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unless otherwise stated.and frequently requires administration of vasoactive
medication if surgical stimulation remains absent for
a significant time. These agents may however jeopardize
hemodynamic stability and tissue oxygenation [1]. Yet,
particular surgical interventions require a sustained high
level of analgesia, although only occasional but intense
nociceptive stimuli occur in between long periods of
low stimulation. In these fluctuating surgical conditions,
maintaining a stable anesthesia (which can, among
other variables, be reflected by a BIS-value between 40
and 60) may be challenging in view of the fluctuating
noxious stimuli. A reliable method to assess the quality. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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which reflects an equal tolerance to typical surgical
stimuli [2].
In addition, many of these surgical interventions have
only limited analgesic needs once the procedure is finished
making the pharmacological profile of remifentanil suitable
for this purpose.
In most surgical conditions, a sound approach to com-
pensate for alternating stimuli would be decreasing the
level of analgesia. However, in many procedures where
continuous muscle relaxants are undesirable and complete
akinesia is nonetheless required, an alternative strategy
must be pursued while addressing obvious concerns re-
garding hemodynamic disturbances and awareness [3].
Furthermore, a safe and fast emergence from anesthesia
with avoidance of sudden increases in intra-ocular or
middle-ear pressure during extubation [4,5], a full coopera-
tive patient soon after surgery and a concise recovery
period is often a pivotal part of the anesthetic management.
Whilst all these desired anesthetic requirements are
being addressed, adequate tissue perfusion and oxygen-
ation must be preserved. Only relying on the arterial blood
pressure to maintain adequate tissue oxygenation is in-
sufficient, yet most advanced hemodynamic monitoring
devices are moderately to highly invasive and are associ-
ated with rare but serious complications limiting their
value in many patients [6-8]. In the surgical settings de-
scribed above (with a substantial percentage of day-case
surgery), non-invasive monitoring (i.e., providing sufficient
information without the risk of inducing complications) is
mandatory. The Inspectra® device (Hutchinson Technology,
Hutchinson, KS, USA) can be used to continuously moni-
tor the tissue oxygen saturation (StO2) non-invasively on
the thenar muscle using near-infrared spectroscopy (NIRS)
[9] while the Nexfin® monitor (Edwards Lifesciences, Irvine,
CA, USA) permits non-invasive measurement of various
hemodynamic variables in a beat-to-beat fashion [9-14].
The aim of this observational study was to describe the
adequacy of tissue oxygenation and hemodynamic sta-
bility together with the quality of the surgical conditions
and emergence from anesthesia in a tightly-specified
balanced anesthesia with a high-antinociceptive contribu-
tion combined with a goal-directed fluid and vasopressor
therapy.
Methods
After the Institutional Ethics Committee approval (Ref:
2012.052, Ethics Committee, University Medical Center
Groningen, Groningen, The Netherlands), 40 consecu-
tive adult patients scheduled for a day-case surgery
under general anesthesia were recorded and written in-
formed consent was asked for data-analysis. The study
was registered at Current Controlled Clinical Trials
(ISRCTN20153044).Anesthetic management
One gram of Paracetamol was administered orally prior
to admission to the OR. Intravenous access was secured
using an 18G IV catheter in a left large forearm vein,
and a continuous background infusion of crystalloids
was started at 90 ml hr−1. Anesthesia was induced with
remifentanil (1 μg kg−1), propofol (1–3 mg kg−1), and
cisatracurium (0.1 mg kg−1).
In patients with preexisting cardiovascular comorbidi-
ties such as hypertension, reported peripheral or coronary
artery disease in whom post-induction hypotension—
defined as a 20% decrease [15,16] in baseline mean arter-
ial pressure (MAP)—can be expected, a norepinephrine
(10 μg) single bolus was co-administered prophylactically.
After tracheal intubation, the lungs were ventilated in
a volume controlled mode with a tidal volume of
8 ml kg−1 lean body weight with a mixture of O2/air
(FiO2 0.4) and 5 cm H2O PEEP. The respiratory rate was
adjusted to keep an end-tidal CO2 pressure between 4.5
and 5.5 kPa.
Anesthesia was maintained with propofol (4 mg kg−1 hr−1)
and remifentanil (0.25 μg kg−1 min−1) and adequate doses
of hypnotics and analgesics to tolerate laryngoscopy [2,17]
and to keep BIS between 40 and 60. If necessary, these
doses could be increased in 30% steps. In addition, nor-
epinephrine was infused as required to keep MAP above
80% of individual baseline (preoperative ambulatory pres-
sure) [15,16].
The level of respiratory induced variation in the pulse
oximetry plethysmographic waveform amplitude (ΔPOP)
[18] was assessed 2 min after intubation; if it was found
to be above 10%, hypovolemia was assumed and a fluid
bolus of 500 ml colloid solution (Voluven®, Fresenius,
Bad Homburg, Germany) was administered.
Administration of propofol, remifentanil, and norepin-
ephrine was stopped simultaneously when the surgical
procedure was finished. The trachea was extubated
under continuous suction only after the patients were
consciously responding and after they deeply inhaled
upon verbal command. The extubation time, defined as
the time between cessation of the syringe pumps and
the moment of extubation, was recorded together with the
incidence of any coughing reflex upon extubation. Any
patient movement during the procedure was recorded.
Two hours after recovery from anesthesia, patients were
explicitly asked for any (adverse) experience in the peri-
anesthetic period.
Monitoring
In addition to standard monitoring, a bispectral index
(BIS) sensor (Aspect Medical Systems, Norwood, MA,
USA) was placed on the forehead [19,20]. The non-invasive
Inspectra® device (Model 650, Hutchinson Technology,
Hutchinson, KA, USA) measures the peripheral StO2
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emits near-infrared light (600–800 nm) to the tissue,
which then undergoes changes in its spectrum, mostly
depending on the degree of microvascular hemoglobin
saturation. The probe can be placed on different ana-
tomical locations; but it was placed on the left thenar
eminence because of the limited fat-layer with little
inter-individual variation [9]. The anesthetist was blinded
for StO2 readings. The Nexfin® monitor (model 1) is a
non-invasive advanced hemodynamic monitoring device
with a working principle that is based on the volume
clamp method using a photoplethysmograph and an in-
flatable cuff placed around the intermediate phalanx [21].
This device provides continuous calculation of arterial
blood pressure, systemic vascular resistance, stroke vol-
ume, cardiac output (CO), and heart rate in a beat-to-beat
fashion [10-14].
Data registration and analysis
The Philips MP70 anesthesia monitor (Philips, Eindhoven,
Netherlands) was connected to a PC, and all patient data
were recorded at a 1-s interval using Rugloop II data-
manager software (Demed, Temse, Belgium). The time
and dose of all administered drugs were recorded in the
Rugloop system, together with any noteworthy events or
patient responses. The following variables were recorded:
SpO2, StO2, heart rate (HR), MAP, CO, Cardiac Index
(CI), and BIS. The electronic data were imported into
Microsoft Excel 2010® (Microsoft, Redmond, WA, USA).
After a graphical representation, a visual inspection of the
data plots was performed to correct obvious atypical
values caused by artifacts.
Statistics
All statistics were performed using Microsoft Excel
2010® and PASW Statistics 18 (SPSS Inc, Chicago, IL,
USA). Data were expressed as mean (SD), median (range),
or number of patients (%). Normality of continuous vari-
ables was assessed using the Kolmogorov-Smirnov test.
Continuous repetitive data before induction, and at 20
and 60 min thereafter were compared using the paired
t test. Statistical significance level was set at p <0.05.
Results
A total of 40 consecutive patients were screened for eli-
gibility and subsequently enrolled.
Forty consecutive patients scheduled for ophthalmic
surgery under general anesthesia were recorded. Mean
(SD) age was 64 (13) years, weight was 82 (14) kg, and
height was 176 (10) cm. There were 11, 23, and 6 patients
of ASA classifications I, II, and III respectively. The me-
dian (range) duration of surgery was 73 (30–184) min. No
use of neuromuscular reversal agents was necessary. In
two patients (5%), an increase in the dosage of bothpropofol and remifentanil was required, whereas in one
patient (2.5%), only the dosage of propofol was increased.
Overall, the median (range) administration rate of nor-
epinephrine was 0.05 (0.00–0.10) μg kg−1 min−1. Thirty-two
patients were given a prophylactic dose of 10 μg norepin-
ephrine at induction of anesthesia. Twenty-one patients
were administered 0.05 μg kg−1 min−1 norepinephrine
continuously, while in eight patients, this administration
rate could be either reduced to 0.025 μg kg−1 min−1 or
stopped. In two patients, the administration rate was in-
creased to 0.075 μg kg−1 min−1 and in one patient to
0.1 μg kg−1 min−1. Eight patients did not receive norepin-
ephrine at all. Thirteen of the forty patients showed a
ΔPOP above 10% and were subsequently administered
500 ml fluid.
Evolution of hemodynamic variables and bispectral index
Figure 1A,B,C,D,E shows the time course of both the in-
dividual and mean values (in bold) of the investigated
variables for the first 90 min. All data were synchronized
at the start of induction of anesthesia. Figure 2 shows
the mean values of all the investigated variables with a
time interval of 1 min.
MAP decreased significantly from 109 (16) to 83 (14)
mmHg (p <0.05) after induction and remained stable
afterwards. No inadvertent severe hypertension following
prophylactic norepinephrine administration was observed
at induction (Figure 1A). Heart rate also decreased
upon induction of anesthesia from 73 (12) to 54 (8)
bpm (p <0.05) but remained stable afterwards (56 (9)
bpm at 60 min; non-significant vs. 20 min). After an
initial drop in cardiac index from 3.0 (0.7) L min−1 m−2 at
induction to 2.1 (0.4) L min−1 m−2 at 20 min thereafter
(p <0.05), it gradually increased again to 2.4 (0.4) L min
m−2 (p <0.05) at 60 min. StO2 increased significantly
within minutes after induction of anesthesia from 83
(6)% before induction to 86 (4)% at 20 min after induc-
tion of anesthesia (p <0.05) to remain stable thereafter
(87 (4)% at 60 min after induction of anesthesia). The
mean (SD) BIS value dropped from 95 (4) before induc-
tion to 44 (9) after 20 min (p <0.05) and remained stable
afterwards (mean BIS 44 (10) at 60 min).
Figure 3 shows the changes in CI and StO2 from pre-
anesthesia level to 20 min after induction in a scatterplot.
Accordingly, a majority of patients have an increased StO2
despite decreased CI. There was no significant correlation
between CI and StO2 values.
Quality of surgical conditions
Complete akinesia was realized in all patients in the
period between induction of anesthesia and the end of
surgery, while no additional relaxant was administered
after intubation and 90% of the cases lasted longer than
45 min. No neuromuscular reversal agents were needed.
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Figure 1 Evolution of individual values (grey), mean value
(black), and 10th and 90th percentile (blue). (A) Mean arterial
pressure. (B) Heart rate. (C) Cardiac index. (D) Tissue oxygen saturation.
(E) Bispectral index. Values are shown from the moment of induction
of anesthesia up to the end of the procedure. Mean and percentiles
are shown for the first 90 minutes.
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s with an interquartile range of 253–386 s. None of the
patients exhibited a coughing reflex upon extubation and
none of the patients reported awareness or unpleasant
experiences in the peri-anesthetic period upon explicit
questioning 2 h after extubation.
Discussion
In this prospective study in 40 patients, we have shown
that during a high-antinociceptive balanced general
anesthesia with propofol and remifentanil, goal-directed
fluid administration and vasopressor support with nor-
epinephrine results in a hemodynamically stable proced-
ure with preservation of tissue oxygen saturation. This
study performed in patients undergoing surgery with
minimal noxious stimuli most of the time allows optimal
quantification of the diverse effects of the anesthetic man-
agement with minimal interference of the surgical proced-
ure. The combination of propofol/remifentanil, reported
to provide an optimal depth of anesthesia, was also se-
lected to produce a level of analgesia providing tolerance
to laryngoscopy in >80% of cases (ED80) [2]. However,
administration of analgesics to reach this high probability
of tolerance to laryngoscopy requires a corresponding de-
crease in hypnotics in order to prevent excessive depth of
anesthesia. Low BIS values (less than 30–40) are indicative
of burst suppression [22], which is not considered a
physiological EEG pattern, and has been correlated with
poor outcome [16,23]. An appropriate decrease in propo-
fol level is adequately reflected in a fitting mean (SD) BIS
value of 44. This high level of antinociception proved to
provide excellent analgesic and hypnotic conditions dur-
ing surgery while also preventing intra- or postoperative
events that might lead to increases in intra-ocular pressure
or pharyngeal reflexes albeit allowing quick extubation
with eventless recovery.
Critique of the methods
Firstly, the current study was neither designed as a ran-
domized controlled trial nor has there been a control
group. The study was nonetheless aimed to elucidate
the effects of a balanced high-antinociceptive general
anesthesia on tissue oxygen saturation in a clinical setting,
for which an observational study would be the most
appropriate.
Secondly, the current study was performed solely in
patients undergoing ophthalmic surgery and therefore
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Figure 2 Time course of HR (bpm), BIS, MAP (mmHg), CI (L min−1 m−2), and StO2 (%). The variables are shown as mean values from
induction of anesthesia up to 90 minutes thereafter. Furthermore, the percentage of the population at each time point that is still included
is shown.
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this anesthetic regimen would be applicable during other
types of surgery. Nevertheless, we speculate that in other
surgical procedures associated with intermittent painful
stimuli but requiring absolute akinesia (e.g., rigid laryngos-
copy) and subsequently requiring rapid recovery with a
fully responsive and cooperative patient, the investigated
high-antinociceptive balanced anesthesia might be of par-
ticular use. Further studies should address this issue.
While invasive measurements are conventionally pre-
ferred to continuously assess hemodynamic variables, we
used the non-invasive Nexfin® device, for which accuracy
and precision of MAP measurements were recently
shown, to meet the Association for the Advancement of
Medical Instrumentation criteria in patients undergoing
thoracic surgery [24] and also, were shown to be not in-
ferior to noninvasive cuff manometric measurement of
MAP in hemodynamically stable patients under general
anesthesia [10]. This device also measures CO with a
percentage error (PE) between 23% and 26% compared
to thermodilution derived CO measurements as reported
for patients who are awake before and after coronary ar-
tery bypass surgery [25]. Another study [14], investigating
the influence of phenylephrine infusion on Nexfin® CO
measurements, found a high concordance (94%) betweenphenylephrine-induced changes in CO measured by
Nexfin® and by esophageal Doppler. The PE found in
this study was however relatively high with a PE of 33%
before and 42.5% after phenylephrine infusion, suggest-
ing a reduced accuracy after vasopressor administration.
Yet, Nexfin® CO accuracy still requires further investiga-
tion in patients under general anesthesia and in situations
such as hemodynamic instability or during infusion of
(other) vasoactive drugs, e.g., norepinephrine. Neverthe-
less, this device allows continuous and non-invasive
monitoring of blood pressure and flow without adding
additional risk to the patient. Additionally, recent techno-
logic advances have also allowed the ability to calculate
dynamic preload variables, such as pulse pressure and
stroke volume variation, in an automated continuous
noninvasive fashion [18], yet with a reported [26] higher
accuracy in assessing fluid responsiveness than clinical
ΔPOP assessment, as was performed in the current study.
Finally, the site and technology to determine tissue
oxygenation may have some limitations. In particular,
myoglobin can have relatively high oxygen saturation
even in case of tissue hypoperfusion and decreased oxy-
genation, and it could be a major contributor to the
readings obtained. As a consequence, there is a debate
on which site should be preferred to accurately measure
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Figure 3 The change in CI and StO2 between pre-anesthesia level and 20 min after induction.
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to baseline we observed in the current study convincingly
demonstrates a favorable mixed effect of the anesthesia on
global StO2.
Quality of surgical conditions and emergence from
anesthesia
In many surgical situations, a balanced high-antinocicep-
tive general anesthesia is indicated, and a combination
of propofol/remifentanil is appreciated. Based on the
pharmacodynamic principle of equivalent anesthetic
depth at different ratios of hypnotic/opiate, the chosen
combination of propofol/remifentanil induced a suffi-
cient level of anesthesia—reflected in normal BIS values
between 40–60—although with a relatively higher contri-
bution of remifentanil [2], resulting in a higher tolerance
for sudden noxious stimuli. The favorable pharmacoki-
netic profile of this remifentanil/propofol combination
resulted in a short median time to extubation—defined
as the time interval between stopping the syringe
pumps and the moment of extubation—of 311 s with
low variability, together with optimal recurrence condi-
tions: the fast elimination of propofol with still adequate
analgesia at extubation results at the moment of endo-
tracheal extubation in a complete suppression of po-
tentially deleterious coughing reflexes and appropriate
cooperation in all patients.Hemodynamics and tissue oxygenation
Anesthesia was induced with propofol, 1–3 mg kg−1, and
remifentanil, 1 μg kg−1: a combination that can acutely
decrease vascular tonus, heart rate, and cardiac output
with resulting relative hypotension [28], which was also
observed in the current study (Figure 2).
Firstly, in order to preserve cardiac preload, 13/40
patients were administered fluid as the ΔPOP value
was >10%, indicating fluid responsiveness, i.e., cardiac
preload dependency.
Secondly, the decrease in CI following anesthesia induc-
tion is largely attributable to the (remifentanil-induced)
decrease in heart rate (Figure 2), while stroke volume
itself was relatively maintained probably because of both
increased cardiac filling time and anesthesia-induced per-
ipheral vasodilation and reduced cardiac afterload. The
decrease in blood pressure after induction of anesthesia
was anticipated with a single bolus of 10 μg norepineph-
rine at induction and a concomitantly started background
infusion of norepinephrine. Most importantly, the admin-
istration of norepinephrine at the reported dose, in com-
bination with goal-directed fluid optimization, was able to
preserve a MAP at 80% of individual baseline values with
a benign decrease in CO and without exerting adverse
effects on StO2.
A major concern of combining potent hypnotics/
analgetics with a vasopressor is a negative end-effect
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Therefore, a rational dosing is essential to obtain the
desired intubation conditions and surgical stability,
with optimal preservation of hemodynamic homeostasis.
The stable BIS value within the recommended range
reflects an adequate and reliable depth of hypnosis and
demonstrates that a strong antinociceptive effect can be
safely obtained if combined with an adequately adapted
administration of propofol. Secondary, while the slight
increase in tissue oxygenation is reassuring, a significant
decrease in CI between awake and post-induction state
demonstrates the potent hemodynamic effects of induc-
tion of even a balanced anesthesia. This decrease in CI is
mainly based on a decrease in systemic resistance and
heart rate and a preserved stroke volume. The resulting
decrease in cardiac oxygen consumption, combined with a
preserved peripheral tissue oxygenation, suggests that a CI
decrease to this extent can be considered acceptable for
induction of anesthesia. The subsequent increase in CI
and stable MAP and StO2 demonstrates that the moderate
continuous doses of vasopressor are sufficient and appro-
priate to sustain hemodynamic stability during guaranteed
optimal surgical conditions. However, the potent effects of
the vasopressors must be reckoned with and must be con-
sidered in respect to other cardiovascular comorbidities.
In addition, a more subtle administration of hypnotics/
analgetics, such as based on TCI models, may be more
appropriate in vulnerable patients.
While this desired MAP may appear relatively high for
some clinicians, several reports [15,16] acknowledge the
utmost importance of a preserved MAP up this value to
prevent adverse outcome. Importantly, care must be taken
that potent vasopressors like norepinephrine are adminis-
tered with respect to appropriate safety measures, such
as the preferable use of a dedicated line and avoidance
of inadvertent boluses.
For patients under general anesthesia, StO2 values
around 80% are considered within the normal range [29].
The increase in StO2 to 86(4)% in our study was most
probably caused by peripheral vasodilation due to the
combination of propofol and remifentanil. This finding is
in contrast to a previous study in which no differences in
StO2 were found before and after induction of anesthesia
[29]. The use of sufentanil in this previous study may
account for this difference. Nevertheless, StO2 is believed
to be a flow-dependent variable [9]. Furthermore, it has
been shown to be independent of MAP and remained
almost constant at different levels of MAP [30]. It has
however not yet been investigated whether thenar StO2
values also correlate with oxygen saturation of tissues of
vital importance (e.g., heart, brain, kidney, liver). Subse-
quently, although the data show favorable values of thenar
StO2, indicating adequate peripheral tissue oxygenation
(at least in the range of MAP and CI values observed),‘macro’ hemodynamic values such as CI, heart rate, and
MAP are of great importance for assuring patient safety.
Conclusions
A high-antinociceptive balanced anesthesia with goal-
directed fluid and norepinephrine administration pre-
served tissue oxygen saturation while other hemodynamic
variables remained within a clinically acceptable range.
Furthermore, this approach provided reliable surgical
conditions, complete akinesia, and swift postoperative
recovery.
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